The DOI matches its Crossref record; 733 of the 733 references it cites were found in a registry or an index.
Efflux-mediated antimicrobial resistance
Abstract
Antibiotic resistance continues to plague antimicrobial chemotherapy of infectious disease. And while true biocide resistance is as yet unrealized, in vitro and in vivo episodes of reduced biocide susceptibility are common and the history of antibiotic resistance should not be ignored in the development and use of biocidal agents. Efflux mechanisms of resistance, both drug specific and multidrug, are important determinants of intrinsic and/or acquired resistance to these antimicrobials, with some accommodating both antibiotics and biocides. This latter raises the spectre (as yet generally unrealized) of biocide selection of multiple antibiotic-resistant organisms. Multidrug efflux mechanisms are broadly conserved in bacteria, are almost invariably chromosome-encoded and their expression in many instances results from mutations in regulatory genes. In contrast, drug-specific efflux mechanisms are generally encoded by plasmids and/or other mobile genetic elements (transposons, integrons) that carry additional resistance genes, and so their ready acquisition is compounded by their association with multidrug resistance. While there is some support for the latter efflux systems arising from efflux determinants of self-protection in antibiotic-producing Streptomyces spp. and, thus, intended as drug exporters, increasingly, chromosomal multidrug efflux determinants, at least in Gram-negative bacteria, appear not to be intended as drug exporters but as exporters with, perhaps, a variety of other roles in bacterial cells. Still, given the clinical significance of multidrug (and drug-specific) exporters, efflux must be considered in formulating strategies/approaches to treating drug-resistant infections, both in the development of new agents, for example, less impacted by efflux and in targeting efflux directly with efflux inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of multidrug efflux-related genes such as mexX, mexY and patB further supports the hypothesis that fluoride exposure may indirectly shape oral resistance by modulating bacterial stress response [58].”
From Severity-dependent alterations in oral microbiota and antibiotic resistance in children with dental fluorosis (2026) · cites this paper as [58]
In the citing paper
“Importantly, many of these pumps affect tetracycline and doxycycline, but do not decrease minocycline or tigecycline susceptibility, as they are not able to use these compounds as substrates (44, 47).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [44]
In the citing paper
“Finally, another predicted efflux pump is Lsa (encoded by the chromosomal gene lsa), which is responsible for the intrinsic resistance of E. faecalis to lincosamides and streptogramin A (LSA phenotype) (44, 45).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [44]
In the citing paper
“These systems may be substrate-specific (for a particular antibiotic such as tet determinants for tetracycline and mef genes for macrolides in pneumococci) or with broad substrate specificity, which are usually found in MDR bacteria (44).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [44]
Citations
Cites
1 retracted
RETRACTED: Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli
Ma, C., & Chang, G. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400137101 · Cited by 102
RetractedAntiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell, G. E., & Russell, A. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.147 · Cited by 4,795
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. M. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,152
Understanding biofilm resistance to antibacterial agents
Davies, D. G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,786
Survival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,797
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,745
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Efflux-mediated heavy metal resistance in prokaryotes
Nies, D. H. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00048-2 · Cited by 1,567
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,523
An Enzyme from Bacteria able to Destroy Penicillin
Abraham, E. P., & Chain, E. B. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,335
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Bacterial silver resistance: molecular biology and uses and misuses of silver compounds
Silver, S. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00047-0 · Cited by 1,312
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T., Pitts, B., Pellock, B. J., Walker, G. C., Stewart, P. S., & O’Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Proton-dependent multidrug efflux systems
Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996) · Microbiological Reviews · doi:10.1128/mr.60.4.575-608.1996 · Cited by 1,089
Koronakis, V. E., Sharff, A., Koronakis, E., Luisi, B. F., & Hughes, C. (2000) · Nature · doi:10.1038/35016007 · Cited by 1,086
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Lomovskaya, O., Warren, M. S., Lee, A. Y., Galazzo, J. L., Fronko, R. M., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J. A., Courvalin, P. M., Jensen, L. B., Rood, J. I., & Seppälä, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
Multiplex PCR for the detection of tetracycline resistant genes
Ng, L. ‐., Martín, I., Alfa, M. J., & Mulvey, M. R. (2001) · Molecular and Cellular Probes · doi:10.1006/mcpr.2001.0363 · Cited by 872
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 811
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 803
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
Schwarz, Š., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.04.001 · Cited by 803
Mechanisms of Solvent Tolerance in Gram-Negative Bacteria
Ramos, J. L., Duque, E., Gallegos, M., Godoy, P., Ramos‐González, M. I., Rojas, A., Terán, W., & Segura, A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161038 · Cited by 792
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism
Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., & Yamaguchi, A. (2006) · Nature · doi:10.1038/nature05076 · Cited by 772
Kampf, G., & Krämer, A. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.863-893.2004 · Cited by 760
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 720
Roberts, M. C. (1996) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.1996.tb00251.x · Cited by 689
Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli
Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.20.5803-5812.2001 · Cited by 667
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Harbarth, S., Garbino, J., Pugin, J., Romand, J. A., Lew, D., & Pittet, D. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.005 · Cited by 630
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 612
Self-citationMcMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Genes acrA and acrB encode a stress‐induced efflux system of Escherichia coli
Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., & Hearst, J. E. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02390.x · Cited by 602
Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism
Seeger, M. A., Schiefner, A., Eicher, T., Verrey, F., Diederichs, K., & Pos, K. M. (2006) · Science · doi:10.1126/science.1131542 · Cited by 590
Strommenger, B., Kettlitz, C., Werner, G., & Witte, W. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4089-4094.2003 · Cited by 579
Lina, G., Quaglia, A., Reverdy, M. E., Leclercq, R., Vandenesch, F., & Étienne, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1062 · Cited by 547
Bacterial efflux pump inhibitors from natural sources
Stavri, M., Piddock, L. J. V., & Gibbons, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl460 · Cited by 547
CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni
Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2124-2131.2002 · Cited by 529
Antimicrobial resistance of Pseudomonas aeruginosa biofilms
Drenkard, E. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.08.009 · Cited by 521
Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials
Tegos, G. P., Stermitz, F. R., Lomovskaya, O., & Lewis, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3133-3141.2002 · Cited by 518
Mechanisms of bacterial biocide and antibiotic resistance
Poole, K. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.8.x · Cited by 508
Self-citationOxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms
Borriello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D., & Stewart, P. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2659-2664.2004 · Cited by 483
Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., & Konno, M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.6942-6949.1990 · Cited by 479
Molecular basis for resistance to silver cations in Salmonella
Gupta, A. K., Matsui, K., Lo, J., & Silver, S. D. (1999) · Nature Medicine · doi:10.1038/5545 · Cited by 474
Active efflux of bile salts by Escherichia coli
Thanassi, D. G., Cheng, L. W., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2512-2518.1997 · Cited by 471
Rosenberg, E. Y., Bertenthal, D., Nilles, M. L., Bertrand, K. P., & Nikaido, H. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03531.x · Cited by 469
Aminoglycoside Resistance in Pseudomonas aeruginosa
Poole, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.479-487.2005 · Cited by 469
Self-citationSáenz, Y., Briñas, L., Domínguez, E., Ruiz, J., Zarazaga, M., Vilà, J., & Torres, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3996-4001.2004 · Cited by 464
Blot, S. I., Vandewoude, K., Hoste, E. A. J., & COLARDYN, F. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2229 · Cited by 462
Lomovskaya, O., & Bostian, K. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.008 · Cited by 461
Proton-dependent multidrug efflux systems.
Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.4.575-608.1996 · Cited by 448
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
Poole, K. (2001) · PubMed · Cited by 445
Self-citationEvolution and spread of antibiotic resistance
Normark, B. H., & Normark, S. J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01026.x · Cited by 441
Triclosan: a widely used biocide and its link to antibiotics
Schweizer, H. P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10772.x · Cited by 434
Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.428-432.2001 · Cited by 427
Regulation of bacterial drug export systems
Grkovic, S., Brown, M. H., & Skurray, R. A. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.4.671-701.2002 · Cited by 423
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus
Kaatz, G. W., Seo, S. M., & Ruble, C. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1086 · Cited by 415
Randall, L. P. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh070 · Cited by 410
Quale, J. M., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Marchand, I., Damier-Piolle, L., Courvalin, P. M., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 406
Active efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 403
Comparative Genome Sequencing for Discovery of Novel Polymorphisms in Bacillus anthracis
Read, T. D., Salzberg, S. L., Pop, M., Shumway, M. F., Umayam, L. A., Jiang, L., Holtzapple, E., Busch, J. D., Smith, K. L., Schupp, J. M., et al. (2002) · Science · doi:10.1126/science.1071837 · Cited by 403
The mar regulon: multiple resistance to antibiotics and other toxic chemicals
Alekshun, M. N., & Levy, S. B. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01589-9 · Cited by 399
Of Pseudomonas, porins, pumps and carbapenems
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.247 · Cited by 393
Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1778 · Cited by 391
Edgar, R., & Bibi, E. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.7.2274-2280.1997 · Cited by 385
Nishino, K., Latifi, T. N., & Groisman, E. A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04940.x · Cited by 385
Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 372
Self-citationThe physiology and collective recalcitrance of microbial biofilm communities
Gilbert, P., Maira‐Litrán, T., McBain, A. J., Rickard, A. H., & Fw, W. (2002) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(02)46005-5 · Cited by 371
Hagman, K. E., Spratt, B. G., Balthazar, J. T., Pan, W., Judd, R. C., & Shafer, W. M. (1995) · Microbiology · doi:10.1099/13500872-141-3-611 · Cited by 368
Antibacterial and resistance modifying activity of
Oluwatuyi, M., Kaatz, G. W., & Gibbons, S. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.10.009 · Cited by 363
Triclosan and Antimicrobial Resistance in Bacteria: An Overview
Yazdankhah, S. P., Scheie, A. A., H⊘iby, E. A., Lunestad, B.-T., Heir, E., Fotland, T. Ø., Naterstad, K., & Kruse, H. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.83 · Cited by 362
Novel Macrolide-Specific ABC-Type Efflux Transporter in Escherichia coli
Kobayashi, N., Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.19.5639-5644.2001 · Cited by 361
Guerra, B., Junker, E., Schroeter, A., Malorny, B., Lehmann, S., & Helmuth, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg362 · Cited by 361
Resistance to ?-lactam antibiotics
Poole, K. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4060-9 · Cited by 359
Self-citationSequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43
Chen, Y.-T., Chang, H.-Y., Lai, Y.-C., Pan, C.-C., Tsai, S.-F., & Peng, H.-L. (2004) · Gene · doi:10.1016/j.gene.2004.05.008 · Cited by 351
A review of the microbiology, antibiotic usage and resistance in chronic skin wounds
Howell‐Jones, R., Wilson, M. J., Hill, K. E., Howard, A., Price, P., & Thomas, D. W. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh513 · Cited by 348
McMurry, L. M., Oethinger, M. D., & Levy, S. B. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13905.x · Cited by 346
Yerushalmi, H. F., Lebendiker, M., & Schuldiner, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6856 · Cited by 337
Gilbert, P., & McBain, A. J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.189-208.2003 · Cited by 335
Role of mycobacterial efflux transporters in drug resistance: an unresolved question
Rossi, E. D., Aínsa, J. A., & Riccardi, G. (2005) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00002.x · Cited by 324
Paulsen, I. T., Littlejohn, T. G., Rådström, P., Sundström, L., Sköld, O., Swedberg, G., & Skurray, R. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.761 · Cited by 320
Evolution of Two-Component Signal Transduction
Koretke, K. K., Lupas, A. N., Warren, P. V., Rosenberg, M. J., & Brown, J. R. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026297 · Cited by 315
Zhanel, G. G., Homenuik, K., Nichol, K. A., Noreddin, A. M., Vercaigne, L. M., Embil, J. M., Gin, A. S., Karlowsky, J. A., & Hoban, D. J. (2004) · Drugs · doi:10.2165/00003495-200464010-00005 · Cited by 314
Lin, J., Şahin, O., Michel, L. O., & Zhang, Q. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4250-4259.2003 · Cited by 308
Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei
Moore, R. A., DeShazer, D., Reckseidler-Zenteno, S., Weissman, A., & Woods, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.465 · Cited by 304
Quinolone generations: natural history or natural selection?
Ball, P. D. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020889 · Cited by 303
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
Review of Macrolides and Ketolides
Zhanel, G. G., Dueck, M., Hoban, D. J., Vercaigne, L. M., Embil, J. M., Gin, A. S., & Karlowsky, J. A. (2001) · Drugs · doi:10.2165/00003495-200161040-00003 · Cited by 300
ABC-transporters: implications on drug resistance from microorganisms to human cancers
Lage, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00203-6 · Cited by 300
MgrA Is a Multiple Regulator of Two New Efflux Pumps in Staphylococcus aureus
Truong, Q. C., Dunman, P. M., Strahilevitz, J., Projan, S. J., & Hooper, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2395-2405.2005 · Cited by 296
Roberts, M. C. (2003) · Clinical Infectious Diseases · doi:10.1086/367622 · Cited by 295
Bass, L., Liebert, C. A., Lee, M. D., Summers, A. O., White, D. G., Thayer, S. G., & Maurer, J. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2925 · Cited by 291
Nagakubo, S., Nishino, K., Hirata, T., & Yamaguchi, A. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.15.4161-4167.2002 · Cited by 288
Köhler, T., van Delden, C., Curty, L. K., Michea-Hamzehpour, M., & Péchère, J.-C. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5213-5222.2001 · Cited by 287
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286
Baranova, N. N., & Nikaido, H. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.15.4168-4176.2002 · Cited by 285
Wang, H., Dzink-Fox, J., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284
Multidrug Efflux in Pseudomonas aeruginosa Components, Mechanisms and Clinical Significance
Poole, K., & Srikumar, R. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395605 · Cited by 279
Self-citationContribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Kaatz, G. W., McAleese, F., & Seo, S. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1857-1864.2005 · Cited by 279
Structure and function of efflux pumps that confer resistance to drugs
Borges-Walmsley, M. I., McKeegan, K. S., & Walmsley, A. R. (2003) · Biochemical Journal · doi:10.1042/bj20020957 · Cited by 278
Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1797-1802.2004 · Cited by 278
Multidrug resistance in Gram-negative bacteria
Poole, K. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00242-3 · Cited by 277
Self-citationAcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex
Tikhonova, E. B., & Zgurskaya, H. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402230200 · Cited by 276
Akama, H., Matsuura, T., Kashiwagi, S., Hiroshi Yoneyama, C., Narita, S., Tomitake Tsukihara, A., Nakagawa, A., & Nakae, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400164200 · Cited by 275
Braoudaki, M., & Hilton, A. C. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.73-78.2004 · Cited by 273
Inducible NorA-mediated multidrug resistance in Staphylococcus aureus
Kaatz, G. W., & Seo, S. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2650 · Cited by 268
Pseudomonas aeruginosaVirulence Analyzed in aDictyostelium discoideumHost System
Cosson, P., Zulianello, L., Join‐Lambert, O., Faurisson, F., Gebbie, L. K., Benghezal, M., van Delden, C., Curty, L. K., & Köhler, T. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.11.3027-3033.2002 · Cited by 268
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263
AcrD of Escherichia coli Is an Aminoglycoside Efflux Pump
Rosenberg, E. Y., Ma, D., & Nikaido, H. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1754-1756.2000 · Cited by 259
Gill, M. J., Brenwald, N. P., & Wise, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.187 · Cited by 259
Multidrug Efflux Systems Play an Important Role in the Invasiveness of Pseudomonas aeruginosa
Hirakata, Y., Srikumar, R., Poole, K., Gotoh, N., Suematsu, T., Kohno, S., Kamihira, S., Hancock, R. E. W., & Speert, D. P. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020005 · Cited by 256
Self-citationStructure of the periplasmic component of a bacterial drug efflux pump
Higgins, M. K., Bokma, E., Koronakis, E., Hughes, C., & Koronakis, V. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400375101 · Cited by 254
Luo, N., Şahin, O., Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.390-394.2003 · Cited by 251
Ciofu, O., Riis, B. J., Pressler, T., Poulsen, H. E., & Høiby, N. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2276-2282.2005 · Cited by 250
Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis
Tzeng, Y., Ambrose, K. D., Zughaier, S. M., Zhou, X., Miller, Y. K., Shafer, W. M., & Stephens, D. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5387-5396.2005 · Cited by 248
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R. S., Adams, J. M., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Furushita, M., Shiba, T., Maeda, T., Yahata, M., Kaneoka, A., Takahashi, Y., Torii, K., Hasegawa, T., & Ohta, M. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.9.5336-5342.2003 · Cited by 240
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 239
Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis
Li, X.-Z., Zhang, L., & Nikaido, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2415-2423.2004 · Cited by 239
Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236
Crystal Structure of the Drug Discharge Outer Membrane Protein, OprM, of Pseudomonas aeruginosa
Akama, H., Kanemaki, M., Yoshimura, M., Tomitake Tsukihara, A., Kashiwagi, T., Hiroshi Yoneyama, C., Narita, S., Nakagawa, A., & Nakae, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400445200 · Cited by 233
McAleese, F., Petersen, P. J., Ruzin, A. V., Dunman, P. M., Murphy, E., Projan, S. J., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1865-1871.2005 · Cited by 233
The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis
Buckley, A. M., Webber, M. A., Cooles, S. W., Randall, L. P., Ragione, R. M. L., Woodward, M. J., & Piddock, L. J. V. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00671.x · Cited by 231
Aase, B., Sundheim, G., Langsrud, S., & Rørvik, L. M. (2000) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(00)00357-3 · Cited by 230
Chuanchuen, R., Narasaki, C. T., & Schweizer, H. P. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.18.5036-5044.2002 · Cited by 228
Bohnert, J. A., & Kern, W. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.849-852.2005 · Cited by 228
Huys, G. R. B., D'Haene, K., Collard, J., & Swings, J. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.3.1555-1562.2004 · Cited by 227
Macrolide Resistance Genes in Enterococcus spp
Portillo, A., Ruiz‐Larrea, F., Zarazaga, M., Alonso, A., Martínez, J. L., & Torres, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.967-971.2000 · Cited by 227
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1345 · Cited by 226
Nikaido, H., Basina, M., Nguyen, V., & Rosenberg, E. Y. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4686-4692.1998 · Cited by 224
Antibiotics: Where did we go wrong?
Overbye, K. M., & Barrett, J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03285-4 · Cited by 223
Antimicrobials: Modes of Action and Mechanisms of Resistance
McDermott, P. F., Walker, R. D., & White, D. G. (2003) · International Journal of Toxicology · doi:10.1080/10915810305089 · Cited by 223
Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians
Jain, R., & Danziger, L. H. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d592 · Cited by 220
Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., Boyer, E., Chamberland, S., & LEE, V. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1340 · Cited by 219
Maynard, C., Békal, S., Sanschagrin, F., Lévesque, R. C., Brousseau, R., Masson, L., Larivière, S., & Harel, J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5444-5452.2004 · Cited by 217
White, D. G., Hudson, C. R., Maurer, J. J., Ayers, S. L., Zhao, S., Lee, M. D., Bolton, L. F., Foley, T., & Sherwood, J. S. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.12.4593-4598.2000 · Cited by 216
Peschke, U., Schmidt, H., Zhang, H., & Piepersberg, W. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02338.x · Cited by 216
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 216
Plasmid-Encoded Multidrug Efflux Pump Conferring Resistance to Olaquindox in Escherichia coli
Hansen, L. H., Johannesen, E., Burmølle, M., Sørensen, A. H., & Sørensen, S. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3332-3337.2004 · Cited by 214
A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus
Gibbons, S. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg044 · Cited by 213
Oethinger, M. D., Kern, W. V., Jellen-Ritter, A., McMurry, L. M., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.10-13.2000 · Cited by 213
Genome-Wide Transcriptional Response of Chemostat-Cultured Escherichia coli to Zinc
Lee, L. J., Barrett, J. A., & Poole, R. K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.3.1124-1134.2005 · Cited by 213
Lincomycin, clindamycin and their applications
Spížek, J., & Řezanka, T. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1545-7 · Cited by 213
Jerse, A. E., Sharma, N. D., Simms, A. N., Crow, E. T., Snyder, L. A. S., & Shafer, W. M. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5576-5582.2003 · Cited by 209
Boyd, D., Cloeckaert, A., Chaslus-Dancla, E., & Mulvey, M. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1714-1722.2002 · Cited by 209
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin
Zuckerman, J. M. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.010 · Cited by 208
Alonso, A., & Martínez, J. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3079-3086.2000 · Cited by 207
Du, B., Long, Y., Liu, H., Chen, D., Liu, D., Xu, Y., & Xie, X.-L. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1521-1 · Cited by 207
Interactions underlying assembly of the Escherichia coli AcrAB–TolC multidrug efflux system
Touzé, T., Eswaran, J., Bokma, E., Koronakis, E., Hughes, C., & Koronakis, V. E. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04158.x · Cited by 205
Naas, T., Mikami, Y., Imai, T., Poirel, L., & Nordmann, P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.1.235-249.2001 · Cited by 205
Ruzin, A. V., Visalli, M. A., Keeney, D. R., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1017-1022.2005 · Cited by 205
Moken, M. C., McMurry, L. M., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2770 · Cited by 204
Fitness of in vitro selected Pseudomonas aeruginosanalB and nfxB multidrug resistant mutants
Sánchez, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf185 · Cited by 204
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J., Kim, J. M., Lee, J., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 204
Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa
Hirai, K., Suzue, S., Irikura, T., Iyobe, S., & Mitsuhashi, S. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.4.582 · Cited by 201
Yu, E. W., Aires, J., & Nikaido, H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.19.5657-5664.2003 · Cited by 200
Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram- Negative Bacteria
Poole, K. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378454 · Cited by 198
Self-citationLittlejohn, T. G. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90439-u · Cited by 197
Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp.
Payot, S., Bolla, J., Corcoran, D., Fanning, S., Mégraud, F., & Zhang, Q. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.12.032 · Cited by 192
Schmitz, F., Sadurski, R., Kray, A., Boos, M., Geisel, R., Köhrer, K., Verhoef, J., & Fluit, A. C. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.891 · Cited by 192
Bile Salts Modulate Expression of the CmeABC Multidrug Efflux Pump inCampylobacter jejuni
Lin, J., Cagliero, C., Guo, B., Barton, Y.-W., Maurel, M. C., Payot, S., & Zhang, Q. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.21.7417-7424.2005 · Cited by 191
Baucheron, S., Tyler, S. D., Boyd, D. A., Mulvey, M. R., Chaslus-Dancla, E., & Cloeckaert, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3729-3735.2004 · Cited by 191
Burse, A., Weingart, H., & Ullrich, M. S. (2004) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi.2004.17.1.43 · Cited by 191
Zhang, L., Li, X.-Z., & Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.287-293.2000 · Cited by 190
Self-citationGuardabassi, L., Dijkshoorn, L., Collard, J., Olsen, J. E., & Dalsgaard, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-10-929 · Cited by 189
To, M. S., Favrin, S. J., Romanova, N. A., & Griffiths, M. W. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5258-5264.2002 · Cited by 189
Colangeli, R., Helb, D., Sridharan, S., Sun, J., Basil, M. V., Hazbón, M. H., Harbacheuski, R., Megjugorac, N. J., Jacobs, W. R., Holzenburg, A., et al. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04510.x · Cited by 188
Guerra, B., Soto, S. M., Argüelles, J. M., & Mendoza, M. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1305-1308.2001 · Cited by 188
Aínsa, J. A., Blokpoel, M. C. J., Otal, I., Young, D. B., Smet, K. A. L. D., & Martı́n, C. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.22.5836-5843.1998 · Cited by 188
Doi, Y., Yokoyama, K., Yamane, K., Wachino, J., Shibata, N., Yagi, T., Shibayama, K., Kato, H., & Arakawa, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.491-496.2004 · Cited by 187
Baucheron, S., Imberechts, H., Chaslus-Dancla, E., & Cloeckaert, A. (2002) · Microbial Drug Resistance · doi:10.1089/10766290260469543 · Cited by 187
Linares, J. F., López, J. A., Camafeita, E., Albar, J. P., Rojo, F., & Martínez, J. L. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1384-1391.2005 · Cited by 184
NorM of Vibrio parahaemolyticus Is an Na + -Driven Multidrug Efflux Pump
Morita, Y., Kataoka, A., Shiota, S., Mizushima, T., & Tsuchiya, T. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.23.6694-6697.2000 · Cited by 182
Sobel, M. L., McKay, G. A., & Poole, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3202-3207.2003 · Cited by 181
Self-citationBissonnette, L., Champetier, S., Buisson, J. P., & Roy, P. H. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.14.4493-4502.1991 · Cited by 180
Zhao, S., Maurer, J. J., Hubert, S. K., Villena, J. F. D., McDermott, P. F., Meng, J., Ayers, S. L., English, L., & White, D. G. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.01.021 · Cited by 180
Multidrug resistance ABC transporters
Chang, G. A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01085-8 · Cited by 178
Gilmour, M. W., Thomson, N. R., Sanders, M. J., Parkhill, J., & Taylor, D. E. (2004) · Plasmid · doi:10.1016/j.plasmid.2004.06.006 · Cited by 178
Hocquet, D., Vogne, C., Garch, F. E., Véjux, A., Gotoh, N., Lee, A., Lomovskaya, O., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1371-1375.2003 · Cited by 178
Multiple antibiotic resistance in Stenotrophomonas maltophilia
Alonso, A., & Martínez, J. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1140 · Cited by 177
Sobel, M. L., Neshat, S., & Poole, K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1246-1253.2005 · Cited by 177
Self-citationMahamoud, A., Chevalier, J., Davin‐Regli, A., Barbe, J., & Pagès, J. (2006) · Current Drug Targets · doi:10.2174/138945006777709557 · Cited by 177
Veal, W. L., Nicholas, R. A., & Shafer, W. M. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.20.5619-5624.2002 · Cited by 176
Bellmann, A., Vrljic, M., Pátek, M., Sahm, H., Krämer, R., & Eggeling, L. (2001) · Microbiology · doi:10.1099/00221287-147-7-1765 · Cited by 176
Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium
Prouty, A. M., Brodsky, I. E., Falkow, S., & Gunn, J. S. (2004) · Microbiology · doi:10.1099/mic.0.26769-0 · Cited by 176
Dugan, J. W., Rockey, D. D., Jones, L., & Andersen, A. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3989-3995.2004 · Cited by 175
Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis
Pasca, M. R., Guglierame, P., Arcesi, F., Bellinzoni, M., Rossi, E. D., & Riccardi, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3175-3178.2004 · Cited by 173
Daßler, T., Maier, T., Winterhalter, C., & Böck, A. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01924.x · Cited by 172
Osmon, S., Ward, S., Fraser, V. J., & Kollef, M. H. (2004) · CHEST Journal · doi:10.1378/chest.125.2.607 · Cited by 172
Kern, W. V., Steinke, P., Schumacher, A., Schuster, S., von Baum, H., & Bohnert, J. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki445 · Cited by 172
Françoise Van Bambeke, A., Pagès, J., & LEE, V. J. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106777452692 · Cited by 171
Gibreel, A., Tracz, D. M., Nonaka, L., Ngo, T., Connell, S. R., & Taylor, D. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3442-3450.2004 · Cited by 170
Schneiders, T., Amyes, S. G. B., & Levy, S. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2831-2837.2003 · Cited by 169
Research works printed but not linked: 2
- Bartlett JG. 2004 Pocket Book of Infectious Disease Therapy, 12 edn. Baltimore: Lippincott Williams & Wilkins, 2004.
- Kumar A, Worobec EA. Cloning sequencing and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob Agents Chemother2005; 49: 1495–1501. · DOI
Cited by
Sorted by citations
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,622
Call of the wild: antibiotic resistance genes in natural environments
Allen, H. K., Donato, J., Wang, H. H., Cloud-Hansen, K. A., Davies, J., & Handelsman, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2312 · Cited by 2,361
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,776
Metadata
- Authors
- Poole, K.
- Affiliations
- Queen's University (CA)
- Corresponding author
- Poole, Keith
- ORCID
- Poole, Keith
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-24
- Volume
- 56
- Issue
- 1
- Pages
- 20-51
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2131256712
- Cited by
- 1,082
- References
- 733
- Citations by year
- 2026: 37 · 2025: 50 · 2024: 54 · 2023: 54 · 2022: 43 · 2021: 63 · 2020: 57 · 2019: 52 · 2018: 48 · 2017: 52 · 2016: 70 · 2015: 52 · 2014: 61 · 2013: 57 · 2012: 54
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- efflux-mediated resistance, antimicrobial resistance, multidrug efflux pumps, biocide resistance, multidrug resistance, plasmid-encoded resistance genes, integrons, transposable elements, mobile genetic elements, efflux pump inhibitors, Gram-negative bacteria, intrinsic resistance, acquired resistance
- MeSH terms
- Aminoglycosides, Anti-Bacterial Agents, Biological Transport, Chloramphenicol, Tetracycline, Fluoroquinolones, Drug Resistance, Bacterial, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review